-
EP2364087
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2364087
| EP2364087 - 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES AND PBK INHIBITORS CONTAINING THE SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.05.2013 Database last updated on 15.06.2024 | Most recent event Tooltip | 10.05.2013 | Application deemed to be withdrawn | published on 12.06.2013 [2013/24] | Applicant(s) | For all designated states Oncotherapy Science, Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | [2011/37] | Inventor(s) | 01 /
MATSUO, Yo C/o Oncotherapy Science Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi 213-0012 / JP | 02 /
LI, Yingfu 38 Cambridge Avenue Clifton Park NY 12065 / US | 03 /
WALKER, Joel, R. 38 Terry Avenue Schenectady NY 12303 / US | 04 /
AHMED, Feryan 23 Belle Avenue Latham NY 12110 / US | 05 /
OHSAWA, Ryuji C/o Oncotherapy Science Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi 213-0012 / JP | 06 /
HISADA, Shoji C/o Oncotherapy Science Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi, 213-0012 / JP | [2011/37] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2011/37] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 09823973.4 | 30.07.2009 | WO2009US52228 | Priority number, date | US20080109801P | 30.10.2008 Original published format: US 109801 P | [2011/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010051085 | Date: | 06.05.2010 | Language: | EN | [2010/18] | Type: | A1 Application with search report | No.: | EP2364087 | Date: | 14.09.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.05.2010 takes the place of the publication of the European patent application. | [2011/37] | Search report(s) | International search report - published on: | US | 06.05.2010 | (Supplementary) European search report - dispatched on: | EP | 04.05.2012 | Classification | IPC: | A01N43/80, A61K31/415, C07D235/08, C07D401/12, C07D409/04, C07D409/06, C07D409/12 | [2012/22] | CPC: |
C07D235/08 (EP,US);
C07D235/06 (KR);
A61K31/4184 (KR);
A61P35/00 (EP);
A61P43/00 (EP);
C07D235/04 (KR);
C07D401/12 (EP,US);
C07D409/04 (EP,US);
C07D409/06 (EP,US);
C07D409/12 (EP,US)
(-)
|
| Former IPC [2011/37] | A01N43/80, A61K31/415 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | 7-HYDROXY-BENZIMIDAZOL-4-YLMETHANONDERIVATE UND SIE ENTHALTENDE PBK-HEMMER | [2011/37] | English: | 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES AND PBK INHIBITORS CONTAINING THE SAME | [2011/37] | French: | DÉRIVÉS DE 7-HYDROXY-BENZO-IMIDAZOLE-4-YL-MÉTHANONE ET INHIBITEURS DE PBK LES CONTENANT | [2011/37] | Entry into regional phase | 24.05.2011 | National basic fee paid | 24.05.2011 | Search fee paid | 24.05.2011 | Designation fee(s) paid | 24.05.2011 | Examination fee paid | Examination procedure | 24.05.2011 | Examination requested [2011/37] | 07.02.2012 | Amendment by applicant (claims and/or description) | 04.12.2012 | Application deemed to be withdrawn, date of legal effect [2013/24] | 23.01.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/24] | Fees paid | Renewal fee | 24.05.2011 | Renewal fee patent year 03 | 23.07.2012 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] - OUGOLKOV A V ET AL, "INHIBITION OF GSK-3 BETA IDENTIFIES IT AS A NOVEL THERAPEUTIC TARGE IN PANCREATIV CANCER", PANCREAS, RAVEN PRESS, NEW YORK, NY, US, (20041101), vol. 29, doi:10.1097/00006676-200411000-00128, ISSN 0885-3177, page 359, XP008075294 [A] 1-17 * the whole document * DOI: http://dx.doi.org/10.1097/00006676-200411000-00128 | [A] - SHAKOORI A ET AL, "Inhibition of GSK-3[beta] activity attenuates proliferation of human colon cancer cells in rodents", CANCER SCIENCE, JAPANESE CANCER ASSOCIATION, TOKYO, JP, (20070901), vol. 98, no. 9, doi:10.1111/J.1349-7006.2007.00545.X, ISSN 1347-9032, pages 1388 - 1393, XP008096595 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1111/j.1349-7006.2007.00545.x | [A] - CAO QI ET AL, "Glycogen synthase kinase-3 beta (GSK-3 beta) promotes proliferation of ovarian cancer cells in vitro", ZHONGHUA ZHONGLIU ZAZHI - CHINESE JOURNAL OF ONCOLOGY, ZHONGHUA YIXUEHUI, BEIJING, CN, (20061112), vol. 28, no. 11, ISSN 0253-3758, pages 804 - 809, XP008096560 [A] 1-15 * the whole document * | International search | [A]US6288100 (ELOKDAH HASSAN M [US], et al); | [Y]WO2004000817 (PFIZER PROD INC [US], et al); | [X]US7179832 (CHO JOONG MYUNG [KR], et al) |